Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Induced CAR-Macrophages as a Novel Therapeutic Cell Type for Cancer Immune Cell Therapies
Siyu Su, Anhua Lei, Xudong Wang, et al.
Cells (2022) Vol. 11, Iss. 10, pp. 1652-1652
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
Margaret M. Billingsley, Ningqiang Gong, Alvin J. Mukalel, et al.
Small (2023) Vol. 20, Iss. 11
Closed Access | Times Cited: 64
The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
Kaveh Hadiloo, Siavash Taremi, Mahmood Heidari, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 45
Recent Advances in CAR-Based Solid Tumor Immunotherapy
Min Hwa Shin, Eunha Oh, Yun Jeong Kim, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1606-1606
Open Access | Times Cited: 43
Activating innate immune responses repolarizes hPSC-derived CAR macrophages to improve anti-tumor activity
Jun Shen, Shuzhen Lyu, Yingxi Xu, et al.
Cell stem cell (2024) Vol. 31, Iss. 7, pp. 1003-1019.e9
Closed Access | Times Cited: 18
CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro
Maoxuan Liu, Junchen Liu, Ziwei Liang, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3692-3692
Open Access | Times Cited: 41
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodríguez‐Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire
Shaivy Malik, Niti Sureka, Sana Ahuja, et al.
Cell Biology International (2024) Vol. 48, Iss. 10, pp. 1406-1449
Closed Access | Times Cited: 6
CAR-macrophage: Breaking new ground in cellular immunotherapy
Ting Huang, Chenqi Bei, Zhenhua Hu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Moringa oleifera leaf polysaccharides exert anti-lung cancer effects upon targeting TLR4 to reverse the tumor-associated macrophage phenotype and promote T-cell infiltration
Shukai Wang, Qian Hu, Zihao Chang, et al.
Food & Function (2023) Vol. 14, Iss. 10, pp. 4607-4620
Closed Access | Times Cited: 15
Cell Immunotherapy against Melanoma: Clinical Trials Review
Ivan Y. Filin, Yuriy P. Mayasin, Chulpan B. Kharisova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2413-2413
Open Access | Times Cited: 14
Therapeutic utility of engineered myeloid cells in the tumor microenvironment
Alessandro Canella, Prajwal Rajappa
Cancer Gene Therapy (2023) Vol. 30, Iss. 7, pp. 964-972
Open Access | Times Cited: 13
Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner
Miao Zeng, Wei Zhang, Yisheng Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma
Seung Kak Shin, Y. Mishima, Yoonseok Lee, et al.
Journal of Gastroenterology and Hepatology (2025)
Open Access
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
The Interface of Tumour-Associated Macrophages with Dying Cancer Cells in Immuno-Oncology
Isaure Vanmeerbeek, Jannes Govaerts, Raquel S. Laureano, et al.
Cells (2022) Vol. 11, Iss. 23, pp. 3890-3890
Open Access | Times Cited: 17
Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer—Looking Back and Forward
Karolina Okła
Cells (2023) Vol. 12, Iss. 14, pp. 1912-1912
Open Access | Times Cited: 10
Engineering transcriptional regulation for cell-based therapies
Matthias Recktenwald, Evan Hutt, Leah Davis, et al.
SLAS TECHNOLOGY (2024) Vol. 29, Iss. 2, pp. 100121-100121
Open Access | Times Cited: 3
Nanobody-based CAR NK cells for possible immunotherapy of MICA+ tumors
Elisha R. Verhaar, Willemijn J. C. van Keizerswaard, Anouk Knoflook, et al.
PNAS Nexus (2024) Vol. 3, Iss. 5
Open Access | Times Cited: 3
Contemporary Approaches to Immunotherapy of Solid Tumors
A. V. Kuznetsova, Ksenia А. Glukhova, О. П. Попова, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2270-2270
Open Access | Times Cited: 3
The prospect of tumor microenvironment-modulating therapeutical strategies
Dirk Eulberg, Anna Frömming, Kfir Lapid, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Engineering macrophages and their derivatives: A new hope for antitumor therapy
Wei Fang, Haiyang Liu, Yuxiao Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116925-116925
Open Access | Times Cited: 2
Sophisticated genetically engineered macrophages, CAR-Macs, in hitting the bull’s eye for solid cancer immunotherapy approaches
Neşe Ünver
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 7, pp. 3171-3177
Closed Access | Times Cited: 6
A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies
Haley Newman, David T. Teachey
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8600-8600
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top